Qingdao Vland Biotech INC. (SHA:603739)
China · Delayed Price · Currency is CNY 14.75
-0.53 (-3.47%)
May 12, 2026, 3:00 PM CST
SHA:603739 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 105.76 | 97.47 | 62.64 | 80.71 | 69.84 | 132.57 |
Depreciation & Amortization | 116.56 | 116.56 | 110.41 | 73.79 | 65.71 | 51.7 |
Other Amortization | 1.67 | 1.67 | 1.78 | 0.49 | 0.95 | 0.2 |
Loss (Gain) From Sale of Assets | -0.47 | -0.47 | 0.6 | -0 | 0.35 | -0.05 |
Asset Writedown & Restructuring Costs | -25.09 | -25.09 | 0.55 | 3 | - | 1.98 |
Loss (Gain) From Sale of Investments | 0.33 | 0.33 | -7.08 | -15.64 | -3.48 | -7.63 |
Provision & Write-off of Bad Debts | - | - | 3.92 | 12.98 | 11.87 | 7.82 |
Other Operating Activities | 33.15 | 30.8 | 56.57 | 41.5 | 29.97 | 19.65 |
Change in Accounts Receivable | -47.54 | -47.54 | -40.88 | -36.65 | -110.01 | -91.03 |
Change in Inventory | -43.94 | -43.94 | 13.84 | -35.62 | -19.16 | -33.19 |
Change in Accounts Payable | -9.19 | -9.19 | -6.46 | 33.15 | 51.03 | 10.24 |
Operating Cash Flow | 124.59 | 113.95 | 195.41 | 153.59 | 95.31 | 89.51 |
Operating Cash Flow Growth | -42.46% | -41.69% | 27.22% | 61.16% | 6.47% | -48.26% |
Capital Expenditures | -53.44 | -80.01 | -104.72 | -215.64 | -342.02 | -493.58 |
Sale of Property, Plant & Equipment | 0.25 | 0.26 | 2.08 | 0.93 | 0.11 | 0.11 |
Cash Acquisitions | -3.77 | -3.77 | -18.36 | -16.84 | -0.91 | -45.96 |
Divestitures | 2.46 | 2.46 | 0.41 | -0.2 | - | - |
Investment in Securities | 11.06 | -0.02 | 65.43 | -75.81 | -103.12 | -75.43 |
Other Investing Activities | 13.4 | 6.49 | 12.71 | 10.91 | 17.77 | 8.13 |
Investing Cash Flow | -30.05 | -74.59 | -42.46 | -296.66 | -428.17 | -606.73 |
Long-Term Debt Issued | - | 752.99 | 842.68 | 661.27 | 489.55 | 360 |
Total Debt Issued | 750.18 | 752.99 | 842.68 | 661.27 | 489.55 | 360 |
Long-Term Debt Repaid | - | -716.04 | -915.25 | -461.16 | -203.7 | -192.44 |
Total Debt Repaid | -777.18 | -716.04 | -915.25 | -461.16 | -203.7 | -192.44 |
Net Debt Issued (Repaid) | -26.99 | 36.95 | -72.57 | 200.11 | 285.85 | 167.56 |
Issuance of Common Stock | - | - | - | 7.76 | 4.74 | 498.82 |
Common Dividends Paid | -42.45 | -43.01 | -55.23 | -39.77 | -52.77 | -37.79 |
Other Financing Activities | -31.4 | -31.4 | -13.67 | -11.74 | -10.1 | -48.03 |
Financing Cash Flow | -101.63 | -37.46 | -141.47 | 156.36 | 227.72 | 580.56 |
Foreign Exchange Rate Adjustments | -0.18 | -0.18 | 0.13 | 0.73 | 1.07 | -1.47 |
Net Cash Flow | -7.26 | 1.71 | 11.61 | 14.03 | -104.07 | 61.87 |
Free Cash Flow | 71.15 | 33.94 | 90.69 | -62.05 | -246.72 | -404.06 |
Free Cash Flow Growth | -19.04% | -62.58% | - | - | - | - |
Free Cash Flow Margin | 5.08% | 2.48% | 6.87% | -5.18% | -21.21% | -35.11% |
Free Cash Flow Per Share | 0.28 | 0.14 | 0.36 | -0.25 | -0.95 | -1.65 |
Cash Income Tax Paid | 105.19 | 105.19 | 83.84 | 80.82 | 44.62 | 58.15 |
Levered Free Cash Flow | 86.86 | 11.85 | 10.14 | 20.05 | -241.42 | -418.19 |
Unlevered Free Cash Flow | 87.54 | 11.85 | 23.82 | 29.56 | -236.94 | -416.86 |
Change in Working Capital | -107.32 | -107.32 | -33.99 | -43.24 | -79.9 | -116.74 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.